News
HAYWARD, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel ...
HAYWARD, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a development-stage, gene therapy-focused, biotechnology company developing novel ...
(RTTNews) - Benitec Biopharma Inc. (BNTC), Wednesday, announced positive interim results from its Phase 1b/2a clinical study of BB-301, an investigational gene therapy for Oculopharyngeal Muscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback